Fianlimab (Anti-LAG3 / CD223)
Fianlimab (Anti-LAG3 / CD223) (A2995-GRP)
Products
Description
Fianlimab (Anti-LAG3 / CD223) is a human monoclonal antibody that targets the immune checkpoint receptor LAG-3 on T cells. It has anti-tumour activity and can be used in treatment of advanced melanoma. MW :145.72 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2995 |
| Target | CD markers |